Biotest AG provided earnings guidance for the financial year 2020. For the period the company expects sales growth of around 10% for financial year 2020. Earnings in 2020 will be influenced by various factors. Besides the expected expenses of EUR 80 million to EUR 90 million from the Biotest Next Level expansion project. The Board of Management expects EBIT to be between EUR 10 million and EUR 5 million.